Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Two retailers. Same-day layoffs. One very strange CEO succession plan. Are we watching Target prepare for an Amazon buyout?